Showing 381 - 400 results of 583 for search '(( 5 a decrease ) OR ((( a al decrease ) OR ((( m el decrease ) OR ( a la decrease ))))))', query time: 0.14s Refine Results
  1. 381
  2. 382
  3. 383

    Basin of Attraction through Invariant Curves and Dominant Functions by Alsharawi, Ziyad

    Published 2015
    “…We study a second-order difference equation of the form z<inf>n+1</inf> = z<inf>n</inf> F (z<inf>n-1</inf>) + h, where both F (z) and z F (z) are decreasing. …”
    Get full text
    Get full text
  4. 384

    Nonlinear effects in locally resonant nanostrip phononic metasurface at GHz frequencies by Feng Gao (3548)

    Published 2021
    “…Each of the nanostrips is 250 nm wide and is made of a 680-nm-thick SiO<sub>2</sub> layer stacking on 50-nm Al metal electrodes. …”
  5. 385
  6. 386

    Diesel engine vibration analysis using artificial neural networks method: Effect of NH<sub>3</sub> additive in biodiesels by Raja Mazuir Raja Ahsan Shah (17541516)

    Published 2024
    “…The ANN models indicated that a 5 % NH<sub>3</sub> additive decreased engine vibration for HD and PD. …”
  7. 387
  8. 388
  9. 389
  10. 390
  11. 391

    Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP) by Anas Hamad (9545771)

    Published 2023
    “…</p><h2>Other Information</h2><p dir="ltr">Published in: BMC Health Services Research<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1186/s12913-022-08981-5" target="_blank">https://dx.doi.org/10.1186/s12913-022-08981-5</a></p>…”
  12. 392
  13. 393

    Numerical investigation of MIL-101(Cr)/GrO composite performance in adsorption cooling systems by Eman Elsayed (19720093)

    Published 2017
    “…The 5%GrO_phys composite showed a decreased SCP and an increased COP at the same cycle time. …”
  14. 394

    One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes by Goran Petrovski (129836)

    Published 2022
    “…HbA1c decreased from 8.2 ± 1.4% (66 ± 15.3 mmol/mol) at baseline, to 6.7 ± 0.5% (50 ± 5.5 mmol/mol) at 3 months (p = 0.02) and remained stable to 7.1 ± 0.6 (54 ± 6.6 mmol/mol) at 12 months (p = 0.02). …”
  15. 395
  16. 396
  17. 397

    The burden of prostate cancer in North Africa and Middle East, 1990–2019: Findings from the global burden of disease study by Mohsen Abbasi-Kangevari (9714440)

    Published 2022
    “…The YLLs, YLDs, and DALYs of PCa increased by 2% (-11.8-23.1), 108% (75.5-155.1), and 6% (-8.9-28.1). The death rate and DALYs rate attributable to smoking have decreased 12% and 10%, respectively. …”
  18. 398

    Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway by Olfa Khalifa (10914452)

    Published 2022
    “…</p><h2>Other Information</h2><p dir="ltr">Published in: Scientific Reports<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1038/s41598-022-06143-5" target="_blank">https://dx.doi.org/10.1038/s41598-022-06143-5</a></p>…”
  19. 399
  20. 400

    Postmicturition dribble in men with no previous urogenital surgery: Systematic review and meta‐analysis of treatment modalities by Ahmed Albakr (14058051)

    Published 2023
    “…Meta‐analyses of the two PDE5 inhibitors studies showed a large effect size with high heterogeneity for decreased PMD volume favoring PDE5 inhibitors over placebo (g = −0.86, 95% confidence interval [CI] −1.75; 0.02, p = 0.05; I2 = 88%); and a significant improvement equivalent to −1.06 points on the Hallym PMD Questionnaire score with no discernable heterogeneity (95% CI −1.65; −0.47, p = 0.0004; I2 = 0%), favoring PDE5 inhibitors compared to controls.…”